In fact, in an investigation, marked CaMK II was considered as a clinically important determinant of heart disease and it was suggesed that the inhibition of CaMK II can be a highly selective approach for targeting adverse myocardial remodeling linked to β-AR signaling path way62. Here, CAMK2G is linked to heart disorder.